lobaplatin
Showing 1 - 11 of 11
Triple Negative Breast Cancer Trial in Beijing (Eribulin Mesylate, Lobaplatin)
Recruiting
- Triple Negative Breast Cancer
- Eribulin Mesylate
- Lobaplatin
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Sep 15, 2022
Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Hepatocellular Carcinoma Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 1, 2023
Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Liver, Cancer of, Primary Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jan 18, 2023
Colorectal Cancer, Chemo Effect, Surgery Trial (Mitomycin, Lobaplatin)
Not yet recruiting
- Colorectal Cancer
- +4 more
- Mitomycin
- Lobaplatin
- (no location specified)
Feb 18, 2022
Gastric Cancer, Chemo Effect, Surgery Trial in Wuhan (Paclitaxel, Lobaplatin)
Recruiting
- Gastric Cancer
- +4 more
- Paclitaxel
- Lobaplatin
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Feb 18, 2022
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Esophageal Cancer Trial in ZhengZhou (Lobaplatin, Cisplatin)
Completed
- Esophageal Cancer
- Lobaplatin
- Cisplatin
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 26, 2020
Small Cell Lung Carcinoma Trial in Guangzhou (Anlotinib Hydrochloride, Lobaplatin, Etoposide)
Unknown status
- Small Cell Lung Carcinoma
- Anlotinib Hydrochloride
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Guangzhou Medical University
Nov 26, 2019
Acute Toxic Effects, Tumor Responses Trial in Zhuhai (Lobaplatin, linear accelerator)
Completed
- Acute Toxic Effects
- Tumor Responses
- Lobaplatin
- linear accelerator
-
Zhuhai, Guangdong, Chinathe Fifth Hospital Affiliated to Sun Yat-Sen University
Apr 7, 2018
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Guiyang (Lobaplatin, Cisplatin)
Unknown status
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Lobaplatin
- Cisplatin
-
Guiyang, Guizhou, ChinaCancer Hospital of Guizhou Medical University
Apr 14, 2017
Breast Cancer Trial in Harbin (lobaplatin, cisplatin)
Unknown status
- Breast Cancer
- lobaplatin
- cisplatin
-
Harbin, Heilongjiang, ChinaCancer Hospital of Harbin Medical University
Jan 22, 2012